Articles Archives | Page 121 of 128 | Sterne Kessler

Post-Grant Reviews at the Patent Office: How They Could be Used to Challenge Biotech and Pharma Patents

Post-Grant Review May Impact Biosimilars Litigation

Post-Grant Proceedings Are Important For Biosimilars

Portfolios With 4 Legs To Stand On: Animal Drug Patent Tips

Patenting Purified Natural Products by Specific Activity: Eligibility and Enablement

Patentees: Caveat Emptor of the ‘On-Sale Bar’!

Patent Vortex 2014 – Trolls, Innovation, and Return on Investment

Patent Term Extension Not A 1-Trick Pony for Animal Drugs

Patent Term Extension Considerations For Regulated Products

Patent Reform And The New Insurance Market That May Follow